JPMorgan Chase & Co’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.11M Buy
256,443
+85,653
+50% +$369K ﹤0.01% 3671
2025
Q1
$639K Buy
170,790
+152,376
+828% +$570K ﹤0.01% 3891
2024
Q4
$187K Sell
18,414
-73,968
-80% -$750K ﹤0.01% 4555
2024
Q3
$1.15M Buy
92,382
+7,325
+9% +$91.2K ﹤0.01% 3570
2024
Q2
$1.11M Sell
85,057
-6,782
-7% -$88.3K ﹤0.01% 3453
2024
Q1
$2.08M Buy
91,839
+13,098
+17% +$297K ﹤0.01% 3132
2023
Q4
$1.02M Buy
78,741
+2,666
+4% +$34.6K ﹤0.01% 3515
2023
Q3
$1.53M Buy
76,075
+70,113
+1,176% +$1.41M ﹤0.01% 3167
2023
Q2
$160K Sell
5,962
-6,749
-53% -$181K ﹤0.01% 4398
2023
Q1
$742K Sell
12,711
-86,100
-87% -$5.03M ﹤0.01% 3615
2022
Q4
$5.04M Buy
98,811
+86,863
+727% +$4.43M ﹤0.01% 2366
2022
Q3
$978K Sell
11,948
-330
-3% -$27K ﹤0.01% 3378
2022
Q2
$830K Sell
12,278
-35,631
-74% -$2.41M ﹤0.01% 3591
2022
Q1
$5.3M Sell
47,909
-1,651
-3% -$183K ﹤0.01% 2523
2021
Q4
$4.78M Buy
49,560
+18,565
+60% +$1.79M ﹤0.01% 2613
2021
Q3
$2.71M Sell
30,995
-1,220
-4% -$106K ﹤0.01% 2975
2021
Q2
$4.99M Buy
32,215
+9,565
+42% +$1.48M ﹤0.01% 2643
2021
Q1
$3.58M Buy
22,650
+318
+1% +$50.2K ﹤0.01% 2875
2020
Q4
$5.19M Buy
22,332
+1,066
+5% +$248K ﹤0.01% 2405
2020
Q3
$4.65M Buy
21,266
+3,187
+18% +$697K ﹤0.01% 2259
2020
Q2
$5.14M Buy
18,079
+897
+5% +$255K ﹤0.01% 2133
2020
Q1
$4.95M Sell
17,182
-6,650
-28% -$1.92M ﹤0.01% 2012
2019
Q4
$6.85M Buy
23,832
+9,518
+66% +$2.74M ﹤0.01% 2001
2019
Q3
$2.07M Buy
14,314
+630
+5% +$90.9K ﹤0.01% 2713
2019
Q2
$1.26M Sell
13,684
-218
-2% -$20K ﹤0.01% 2930
2019
Q1
$1.22M Buy
13,902
+6,070
+78% +$532K ﹤0.01% 2929
2018
Q4
$1.1M Sell
7,832
-290
-4% -$40.8K ﹤0.01% 2987
2018
Q3
$2.08M Buy
8,122
+19
+0.2% +$4.85K ﹤0.01% 2770
2018
Q2
$2.07M Sell
8,103
-11,188
-58% -$2.85M ﹤0.01% 2796
2018
Q1
$3.88M Sell
19,291
-662
-3% -$133K ﹤0.01% 2367
2017
Q4
$2.87M Sell
19,953
-527
-3% -$75.9K ﹤0.01% 2558
2017
Q3
$3.34M Buy
20,480
+18,081
+754% +$2.95M ﹤0.01% 2395
2017
Q2
$326K Sell
2,399
-32,175
-93% -$4.37M ﹤0.01% 3272
2017
Q1
$6.66M Buy
34,574
+7,082
+26% +$1.36M ﹤0.01% 1931
2016
Q4
$3.88M Buy
27,492
+2,559
+10% +$361K ﹤0.01% 2317
2016
Q3
$3.64M Buy
24,933
+801
+3% +$117K ﹤0.01% 2174
2016
Q2
$2.43M Buy
24,132
+5,452
+29% +$549K ﹤0.01% 2362
2016
Q1
$2.5M Buy
18,680
+4,198
+29% +$562K ﹤0.01% 2283
2015
Q4
$2.88M Buy
14,482
+9,119
+170% +$1.81M ﹤0.01% 2215
2015
Q3
$846K Sell
5,363
-242
-4% -$38.2K ﹤0.01% 2753
2015
Q2
$2.29M Buy
5,605
+2,438
+77% +$995K ﹤0.01% 2456
2015
Q1
$1.45M Sell
3,167
-153
-5% -$70.2K ﹤0.01% 2663
2014
Q4
$1.86M Sell
3,320
-317
-9% -$178K ﹤0.01% 2528
2014
Q3
$1.91M Buy
3,637
+82
+2% +$43K ﹤0.01% 2459
2014
Q2
$2.48M Sell
3,555
-1,208
-25% -$844K ﹤0.01% 2353
2014
Q1
$2.21M Sell
4,763
-2,476
-34% -$1.15M ﹤0.01% 2455
2013
Q4
$2.49M Buy
+7,239
New +$2.49M ﹤0.01% 2422